Five-Year Survival After Monotherapy for Hepatocellular Carcinoma in the Setting of Cirrhosis

Transplantation Proceedings

Volumn 40, Issue 9, 2008, Pages 3204-3205

  Fouzas, I ^a,c   Sotiropoulos, G C ^a,b   Sgourakis, G ^a   Druhe N ^a   Wohlschlaeger, J ^a   Molmenti, E P ^a   Broelsch, C E ^a   Lang, H ^a,b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c Aristotle University of Thessaloniki   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; SORAFENIB;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; SURVIVORS; TIME FACTORS;

EID: 55749104040     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.08.035     Document Type: Article

References (3)

1. Jonas S., Bechstein W.O., and Steinmuller T. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33 (2001) 1080
2. Pawlik T.M., Delman K.A., and Vauthey J.N. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 11 (2005) 1086
3. Sotiropoulos G.C., Lang H., and Nadalin S. Liver transplantation for hepatocellular carcinoma: University Hospital Essen experience and meta-analysis of prognostic factors. J Am Coll Surg 205 (2007) 661